Overview

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

Status:
Completed
Trial end date:
2005-07-29
Target enrollment:
Participant gender:
Summary
Allow physicians not familiar with anti-leukotriene based therapy to test it
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast